Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion type Assertion NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_head.
- NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion description "[In this chapter, we describe the use of immobilized metal affinity chromatography (IMAC) phosphopeptide enrichment followed by reversed-phase liquid chromatography and tandem mass spectrometry (LC-MS/MS) analysis for exploring CXCL12-mediated signaling in human CLL patient cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_provenance.
- NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion evidence source_evidence_literature NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_provenance.
- NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion SIO_000772 19446733 NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_provenance.
- NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion wasDerivedFrom befree-20150227 NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_provenance.
- NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_assertion wasGeneratedBy ECO_0000203 NP688098.RAc4JfjR9imBIxlFCp4sa8AGdkwtBGrSpR6O6haxcklPs130_provenance.